If cagrilintide is approved, it would likely be priced in a similar range to other premium injectable weight-loss medicationsthough the exact number could go in either direction depending on insurance negotiations, patient assistance programs, and competitive dynamics with Zepbound and other competing medications
Metformin has also been reported to prevent human pancreatic islets from impairment of glucose-stimulated insulin secretion induced by high glucose in human pancreatic islets 17
New NCQA HEDIS data shows consistent, year-over-year gains in chronic kidney disease (CKD) testing among people with diabetes across every major payor segment from 2021 to 2024: Commercial HMO: +5.6 pts 49.5% Commercial PPO: +3.3 pts 42.9% Medicaid HMO: +4.2 pts 37.7% Medicare HMO: +8.7 pts 52.9% Medicare PPO: +9.1 pts 49.4% The result
Lenzi A, Sgro P, Salacone P, et al
A 30-day guarantee that is shorter than many competitors offer
For details, see the update in the Multivitamin Supplements Review